Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadi...

FDA Recall #D-0298-2021 — Class III — February 19, 2021

Recall #D-0298-2021 Date: February 19, 2021 Classification: Class III Status: Terminated

Product Description

Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03

Reason for Recall

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Recalling Firm

Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

635,400 cartons

Distribution

USA nationwide, including Puerto Rico.

Code Information

Lot #: 20K0043P, 20K0044P, 20K0042P, Exp 08/2022; 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P, Exp 09/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated